Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13223471 | 0.97 | GAA (0.33) | ALDH1A1SMN1; SMN2LMNAGAAPKM | |
| SCHEMBL1090915 | 0.92 | GAA (0.33) | GAAPKMKDM4EKMT2A | |
| SCHEMBL1091554 | 0.87 | KDM4E (0.38) | LMNAGAABLMPKMKDM4E | |
| SCHEMBL14136846 | 0.86 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL11376972 | 0.86 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL14136780 | 0.83 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2PKM | |
| SCHEMBL28038472 | 0.82 | CYP2C19 (0.30) | CYP2C19 | |
| SCHEMBL22958 | 0.80 | CYP2C19 (0.38) | ALDH1A1SMN1; SMN2LMNATSHRUSP2 | |
| SCHEMBL14825438 | 0.80 | ALDH1A1 (0.31) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL14136865 | 0.78 | PKM (0.30) | PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2903448-A1 | HARD CONFECTIONARY AND METHOD OF MANUFACTURE THEREOF | Intercontinental Great Brands LLC (US) | 2015-08-12 | — | — | EP | claimed |
| CN-104684406-A | Hard confectionery and method of making same | INTERCONTINENTAL GREAT BRANDS LLC | 2015-06-03 | — | — | CN | claimed |
| EP-4630407-A1 | 2-METHYL-2-(1-METHYLCYCLOHEXYL)PROPANAMIDE DERIVATIVES AND 1-(TERT-BUTYL)-CYCLOHEXANE-1-CARBOXAMIDE DERIVATIVES FOR USE IN UMAMI FLAVOR COMPOSITIONS | International Flavors & Fragrances, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4630407-A1 | 2-METHYL-2-(1-METHYLCYCLOHEXYL)PROPANAMIDE DERIVATIVES AND 1-(TERT-BUTYL)-CYCLOHEXANE-1-CARBOXAMIDE DERIVATIVES FOR USE IN UMAMI FLAVOR COMPOSITIONS | International Flavors & Fragrances, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4630407-A1 | 2-METHYL-2-(1-METHYLCYCLOHEXYL)PROPANAMIDE DERIVATIVES AND 1-(TERT-BUTYL)-CYCLOHEXANE-1-CARBOXAMIDE DERIVATIVES FOR USE IN UMAMI FLAVOR COMPOSITIONS | International Flavors & Fragrances, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| CN-120435456-A | 2-Methyl-2- (1-methylcyclohexyl) propanamide derivatives and 1- (tert-butyl) -cyclohexane-1-carboxamide derivatives for umami flavour compositions | 国际香料和香精公司 | 2025-08-05 | — | — | CN | disclosed |
| CN-120435456-A | 2-Methyl-2- (1-methylcyclohexyl) propanamide derivatives and 1- (tert-butyl) -cyclohexane-1-carboxamide derivatives for umami flavour compositions | 国际香料和香精公司 | 2025-08-05 | — | — | CN | disclosed |
| WO-2024123607-A1 | 2-METHYL-2-(1-METHYLCYCLOHEXYL)PROPANAMIDE DERIVATIVES AND 1-(TERT-BUTYL)-CYCLOHEXANE-1-CARBOXAMIDE DERIVATIVES FOR USE IN UMAMI FLAVOR COMPOSITIONS | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| EP-2903448-B1 | HARD CONFECTIONARY AND METHOD OF MANUFACTURE THEREOF | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2021-08-18 | — | — | EP | disclosed |
| WO-2017105634-A1 | CHEWING GUM COMPOSITIONS HAVING CONTROLLED RELEASE OF COOLING AGENTS AND METHODS OF MANUFACTURE | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2017-06-22 | — | — | WO | disclosed |
| US-9504266-B2 | Photodegradable gum base, a chewing gum comprising the photodegradable gum base and methods of making the same | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2016-11-29 | — | — | US | disclosed |
| US-20100204119-A1 | 4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES | PFIZER INC | 2010-08-12 | — | — | US | disclosed |
| US-20050043411-A1 | Process for preparing homophthalate derivatives | TJGEL, LLC | 2005-02-24 | — | — | US | disclosed |
| US-6797838-B2 | Process for preparing homophthalate derivatives | ILEX PRODUCTS, INC. | 2004-09-28 | — | — | US | disclosed |
| EP-1404662-A2 | PROCESS FOR PREPARING ISOCOUMARINS | Ilex Products, Inc. (US) | 2004-04-07 | — | — | EP | disclosed |
| US-20040024240-A1 | Process for preparing homophthalate derivatives | GENZYME CORPORATION | 2004-02-05 | — | — | US | disclosed |
| US-6664401-B2 | Reacting a isochroman-1,3-dione with a carbonyl compound whose carbonyl group is substituted with an acyl activating group, in the presence of a base and a solvent; use making anticancer agents for example | ILEX PRODUCTS, INC. | 2003-12-16 | — | — | US | disclosed |
| US-20030105340-A1 | Process for preparing isocoumarins | GENZYME CORPORATION | 2003-06-05 | — | — | US | disclosed |
| WO-2003004486-A2 | PROCESS FOR PREPARING ISOCOUMARINS | ILEX PRODUCTS, INC. (US) | 2003-01-16 | — | — | WO | disclosed |
| US-4283420-A | ANTICONVULSANTS, ANTIANAPHYLACTIC AGENTS, ANTIPSYCHOTIC AGENTS | LABAZ (FR) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204119-A1 | 4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES | DGAT1, DGAT2, MOGAT2 | ALDH1A1 158/4885SMN1; SMN2 2977/4885LMNA 4019/4885 |
| US-20030105340-A1 | Process for preparing isocoumarins | DHPS, IDH2, IDH1 | ALDH1A1 1178/4885SMN1; SMN2 4741/4885LMNA 2099/4885 |
| US-20050043411-A1 | Process for preparing homophthalate derivatives | HPD, HAAO, PAH | ALDH1A1 669/4885SMN1; SMN2 4831/4885LMNA 1932/4885 |
| US-20040024240-A1 | Process for preparing homophthalate derivatives | HPD, HAAO, PAH | ALDH1A1 669/4885SMN1; SMN2 4831/4885LMNA 1932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.